Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for a seasonal apparel and footwear company: the income statement reveals profitability trends, the cash flow statement shows liquidity generation amid working‑capital seasonality, and the balance sheet reflects the company’s debt‑free position and capital‑return policy.

Composite Trajectory: Mixed

Annual GAAP earnings and operating cash flow have declined for three consecutive years (2023‑2025), with net income falling 30% and operating cash flow falling 56% over that span. Quarterly results for Q2 2026 show sharp GAAP improvements in net income (from a $10.2 million loss to a $26.6 million profit) and operating cash flow (from -$62.9 million to +$37.5 million), but those gains are predominantly driven by a one‑time $78 million recovery of IEEPA tariffs. The balance sheet remains strong with no drawn debt and ample liquidity, though shareholders’ equity has contracted due to sustained share repurchases and dividends amid declining retained earnings.

2. Red Flags

• Multi‑year earnings decline: Net income dropped from $251.4 million (2023) to $223.3 million (2024) to $177.2 million (2025) (10-K 2025-12-31, Consolidated Statements of Operations).
• Operating cash flow erosion: Net cash from operations fell from $636.3 million (2023) to $491.0 million (2024) to $282.9 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• SG&A growing faster than revenue: SG&A rose 4% to $1.50 billion in 2025 while net sales grew only 1% (10-K 2025-12-31, MD&A – SG&A expenses).
• Recurring goodwill/intangible impairments: $25 million in 2023, $0 in 2024, $29 million in 2025 (10-K 2025-12-31, Consolidated Statements of Operations).
• Quarterly profit surge tied to non‑recurring tariff recovery: Q2 2026 operating income of $30.9 million vs. a $23.6 million loss in Q2 2025, with the filing attributing ~980 bps of gross‑margin expansion and ~$0.93 of EPS to IEEPA tariff refunds (10-Q 2026-06-30, MD&A – Gross Profit and Diluted EPS).
• U.S. segment sales declining for three years: U.S. net sales fell from $2.24 billion (2023) to $2.07 billion (2024) to $1.98 billion (2025) (10-K 2025-12-31, Segment net sales).
• Shareholders’ equity declining despite buybacks: Total equity fell from $1.78 billion (Dec 2024) to $1.71 billion (Dec 2025) to $1.60 billion (Jun 2026) while the company repurchased $201 million and $318 million of stock in 2025 and 2024 respectively (10-K 2025-12-31, Consolidated Statements of Equity; 10-Q 2026-06-30, Consolidated Balance Sheets).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP net income has deteriorated for three straight years, falling 30% from $251.4 million (2023) to $177.2 million (2025), with operating margin compressing from 8.9% to 6.1% over the same period (10-K 2025-12-31, Consolidated Statements of Operations). In contrast, the most recent comparable quarter (Q2 2026 vs. Q2 2025) shows GAAP net income swinging from a $10.2 million loss to a $26.6 million profit and diluted EPS from -$0.19 to $0.52 (10-Q 2026-06-30, Condensed Statements of Operations). However, the filing explicitly states that the quarterly improvement was “primarily reflecting an approximate $0.93 benefit from the recovery of IEEPA tariffs previously paid” (10-Q 2026-06-30, MD&A – Diluted EPS). Underlying trends remain weak: U.S. net sales declined 4% in Q2 2026 and 8% year‑to‑date, while consolidated constant‑currency sales were flat to down (10-Q 2026-06-30, MD&A – Net Sales).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow has declined sharply each year: $636.3 million (2023) → $491.0 million (2024) → $282.9 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). The six‑month period ending June 30 2026 shows a reversal, with operating cash flow of $37.5 million versus -$62.9 million in the prior year (10-Q 2026-06-30, Consolidated Statements of Cash Flows). The filing attributes this improvement “primarily driven by the recovery of approximately $78 million of IEEPA tariffs previously paid” (10-Q 2026-06-30, MD&A – Cash Flow Activities). Capital expenditures have risen modestly ($54.6 million in 2023 to $66.2 million in 2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows), so free cash flow (operating cash flow less CapEx) has also trended down annually but benefited from the one‑time tariff recovery in the first half of 2026.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Stable

The company maintains a debt‑free balance sheet with no outstanding borrowings on its $500 million revolving credit facility as of both Dec 31 2025 and Jun 30 2026 (10-K 2025-12-31, Note 11; 10-Q 2026-06-30, Sources of Liquidity). Total assets declined from $2.98 billion (Dec 2024) to $2.93 billion (Dec 2025) to $2.80 billion (Jun 2026), largely reflecting seasonal inventory swings and a shift from short‑term investments to cash (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). Inventories were flat year‑over‑year at $689.5 million (Dec 2025) but rose seasonally to $874.8 million by Jun 2026 (10-Q 2026-06-30, MD&A – Capital Requirements). Shareholders’ equity has contracted from $1.78 billion to $1.71 billion to $1.60 billion over the three dates due to share repurchases ($201 million in 2025, $183 million in H1 2026) and dividends ($65.5 million in 2025, $65.5 million in H1 2026) (10-K 2025-12-31, Consolidated Statements of Equity; 10-Q 2026-06-30, Consolidated Statements of Cash Flows). Liquidity remains ample with $532 million cash and $92 million short‑term investments at Jun 30 2026 (10-Q 2026-06-30, Sources of Liquidity).

6. Data Gaps

• Full quarterly income statements and cash flows for Q1, Q3, and Q4 2026 (only Q2 and YTD Q2 are provided in the 10‑Q).
• FY2026 annual results (not yet filed).
• Segment-level cash flow statements (only consolidated cash flows are disclosed).
• Free cash flow for quarterly periods (non‑GAAP measure not reconciled in the 10‑Q).
• Detailed breakdown of “other segment items” in segment operating income for quarterly periods.
• Impact of the Section 122 tariffs imposed Feb 24 2026 on FY2026 cost of sales and margins (only mentioned qualitatively in Subsequent Events).